Nevro Corp. /
Interventional Pain Technologies, Inc. d/b/a Vyrsa Technologies
Nevro Corp. completes Vyrsa Technologies acquisition




What happened
Nevro Corp. completed its acquisition of Interventional Pain Technologies, Inc. d/b/a Vyrsa Technologies, a Pennsylvania medical device developer. The transaction included approximately $40.0 million in upfront cash consideration, with up to an additional $35.0 million in cash or common stock tied to development and sales milestones.
The source
Everything on this page comes from the source below.
Nevro Corp. completes Vyrsa Technologies acquisition
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly